These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21659914)

  • 1. Intralesional interferon for extensive squamous papilloma of the eyelid margin.
    Lee BJ; Nelson CC
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):e47-8. PubMed ID: 21659914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of recurrent conjunctival papilloma after topical and intralesional interferon alpha2b with partial excision in a child.
    Kothari M; Mody K; Chatterjee D
    J AAPOS; 2009 Oct; 13(5):523-5. PubMed ID: 19840738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dacryoendoscopy-guided transcanalicular intralesional interferon alpha 2b for canalicular squamous papillomas.
    Ali MJ; Singh S; Ganguly A; Naik MN
    Int Ophthalmol; 2018 Jun; 38(3):1343-1346. PubMed ID: 28540494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjunctival papilloma.
    Tseng SH
    Ophthalmology; 2009 May; 116(5):1013-1013.e1. PubMed ID: 19410961
    [No Abstract]   [Full Text] [Related]  

  • 5. Topical interferon alpha 2 beta therapy in the management of conjunctival papilloma.
    Falco LA; Gruosso PJ; Skolnick K; Bejar L
    Optometry; 2007 Apr; 78(4):162-6. PubMed ID: 17400137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery of basal cell carcinoma around the lacrimal canaliculus can be necessary after primary treatment with intralesional interferon alpha 2b.
    Huerva V; Mangues I
    Indian J Ophthalmol; 2008; 56(1):85-6. PubMed ID: 18158420
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term administration of topical interferon alfa-2beta in the treatment of conjunctival squamous papilloma.
    Morgenstern KE; Givan J; Wiley LA
    Arch Ophthalmol; 2003 Jul; 121(7):1052-3. PubMed ID: 12860816
    [No Abstract]   [Full Text] [Related]  

  • 8. Intralesional interferon alfa for treatment of recurrent lentigo maligna of the eyelid in a patient with primary acquired melanosis.
    Carucci JA; Leffell DJ
    Arch Dermatol; 2000 Nov; 136(11):1415-6. PubMed ID: 11074712
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical alpha-interferon in recurrent conjunctival papilloma.
    de Keizer RJ; de Wolff-Rouendaal D
    Acta Ophthalmol Scand; 2003 Apr; 81(2):193-6. PubMed ID: 12752062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional interferon alpha-2b therapy for adnexal Kaposi sarcoma.
    Qureshi YA; Karp CL; Dubovy SR
    Cornea; 2009 Sep; 28(8):941-3. PubMed ID: 19654515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional interferon alfa-2b for refractory, recurrent squamous cell carcinoma of the face.
    Hanlon A; Kim J; Leffell DJ
    J Am Acad Dermatol; 2013 Dec; 69(6):1070-2. PubMed ID: 24238178
    [No Abstract]   [Full Text] [Related]  

  • 12. [Granulomatous slack skin: partial remission following intralesional administration of interferon-alpha and PUVA].
    Schmook T; Hofbauer G; Kempf W; Burg G; Dummer R
    Hautarzt; 2001 Oct; 52(10 Pt 2):985-8. PubMed ID: 11715400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical therapy with imiquimod for eyelid lesion.
    Tsang HH; Huynh NT; Hollenbach E
    Clin Exp Ophthalmol; 2006 Mar; 34(2):179-81. PubMed ID: 16626439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
    Chitwood K; Etzkorn J; Cohen G
    Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival and orbital lymphoma.
    Shinder R
    Ophthalmology; 2011 Aug; 118(8):1692; author reply 1692, 1692.e1. PubMed ID: 21813098
    [No Abstract]   [Full Text] [Related]  

  • 16. Intralesional bevacizumab for cutaneous capillary haemangioma associated with pregnancy.
    Steeples LR; Bonshek R; Morgan L
    Clin Exp Ophthalmol; 2013; 41(4):413-4. PubMed ID: 22957786
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon eyedrops in the treatment of basal cell carcinoma of the eyelid.
    Leis-Dosil VM; Prats-Caelles I; Rubio-Flores C
    Actas Dermosifiliogr; 2014 Mar; 105(2):207-8. PubMed ID: 23608556
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma.
    Hou S; Liu X; Liu J; Zhang Z; Wang B; Han C
    Eur J Dermatol; 2016 Dec; 26(6):629-630. PubMed ID: 27629423
    [No Abstract]   [Full Text] [Related]  

  • 19. Intralesional therapy for the treatment of keratoacanthoma.
    Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
    Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intralesional Bleomycin as an Adjunct Therapeutic Modality in Eyelid and Extraocular Malignancies and Tumors.
    Meyer D; Gooding C
    Middle East Afr J Ophthalmol; 2015; 22(4):410-4. PubMed ID: 26692709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.